日本のアフェレシス市場レポート：成分、製品、技術、施術、用途、エンドユーザー、地域別、2025～2033年

日本のアフェレシス市場規模は2024年に1億4,260万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに2億5,290万米ドルに達し、2025～2033年にかけて6.08%の成長率（CAGR）を示すと予測しています。がん、自己免疫疾患、血液関連疾患などの慢性疾患の罹患率の増加、アフェレシス機器の急速な技術進歩、アフェレシス手技の利点に関するヘルスケア専門家や患者の意識の高まり、ヘルスケアインフラへの多額の投資などが市場を後押しする要因となっています。

本レポートで扱う主要質問

• 日本のアフェレシス市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が日本のアフェレシス市場に与えた影響は？
• 日本のアフェレシス市場の成分別区分は？
• 日本のアフェレシス市場の製品別区分は？
• 日本のアフェレシス市場の技術別区分は？
• 日本のアフェレシス市場の施術別区分は？
• 日本のアフェレシス市場の用途別区分は？
• 日本のアフェレシス市場のエンドユーザー別区分は？
• 日本のアフェレシス市場のバリューチェーンにおける様々なステージとは？
• 日本のアフェレシスの主要な促進要因と課題は何か？
• 日本のアフェレシス市場の構造と主要参入企業は？
• 日本のアフェレシス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本のアフェレシス市場-イントロダクション

• 概要
• 市場力学
• 産業動向
• 競合情報

第5章 日本のアフェレシス市場情勢

• 過去と現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本のアフェレシス市場-成分別内訳

• 血漿（血漿交換）
• 血小板（血小板成分採取）
• 白血球（白血球除去または白血球除去）
• リンパ球（リンパフェレーシスまたはリンパフェレシス）
• 赤血球（赤血球除去）

第7章 日本のアフェレシス市場-製品別内訳

• 機器
• 使い捨て品と試薬
• ソフトウェア

第8章 日本のアフェレシス市場-技術別内訳

• 遠心分離
• 膜分離
• 選択吸着

第9章 日本のアフェレシス市場-施術別内訳

• ドナー/自動アフェレシス
• 治療アフェレシス

第10章 日本のアフェレシス市場-用途別内訳

• 腎疾患
• 血液疾患
• 神経疾患
• 自己免疫疾患
• その他

第11章 日本のアフェレシス市場-エンドユーザー別内訳

• 血液センター
• 病院
• その他

第12章 日本のアフェレシス市場-競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第13章 主要企業のプロファイル

第14章 日本のアフェレシス市場-産業分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第15章 付録

Japan apheresis market size reached USD 142.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 252.9 Million by 2033, exhibiting a growth rate (CAGR) of 6.08% during 2025-2033. The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and blood-related conditions, the rapid technological advancements in apheresis equipment, the rising awareness among healthcare professionals and patients about the benefits of apheresis procedures, and the heavy investments in healthcare infrastructure are some of the factors propelling the market.

Apheresis, a medical procedure with therapeutic applications, involves the separation and removal of specific blood components from a donor or patient. The process utilizes a sophisticated machine known as an apheresis machine, which allows for the selective extraction and retention of blood components, such as plasma, platelets, red blood cells, or white blood cells. This separation is achieved through centrifugation or filtration, depending on the targeted blood component. One of the primary therapeutic applications of it is in the treatment of various medical conditions, including autoimmune disorders, hematologic diseases, and neurological disorders. For example, in autoimmune diseases like multiple sclerosis or myasthenia gravis, apheresis can remove harmful antibodies from the patient's blood, mitigating the impact of the disease. Similarly, in hematologic disorders like leukemia, apheresis aids in collecting specific blood components for therapeutic use or transplantation. Additionally, it plays a crucial role in blood donation processes, allowing for the collection of specific components needed for various medical treatments while returning the remaining components to the donor. This targeted blood component collection enhances the efficiency of blood donation practices, ensuring a steady and diverse supply of blood products for medical interventions. The evolving field of apheresis continues to contribute to advancements in therapeutic and donation-related medical practices, providing clinicians with a powerful tool to selectively manage blood components to benefit patients facing a spectrum of health challenges.

Japan Apheresis Market Trends:

The market in Japan is majorly driven by the expanding scope of therapeutic applications. In line with this, the rapid advancements in apheresis machine technologies contribute significantly to market growth. Continuous innovations in device design, automation, and precision in blood component separation enhance the efficiency and safety of apheresis procedures, making them more accessible and attractive to healthcare providers. These technological enhancements also lead to reduced procedure times and improved patient comfort, further driving the adoption of apheresis in clinical settings. Furthermore, the rising prevalence of chronic and autoimmune diseases fuels the demand for apheresis procedures. Conditions such as cancer, autoimmune disorders, and hematologic diseases often require targeted removal or collection of specific blood components to manage symptoms or facilitate treatments. Apheresis serves as a crucial therapeutic intervention by allowing the selective extraction of disease-related components, contributing to disease management and improving patient outcomes. As the burden of chronic diseases continues to increase, the demand for apheresis procedures as a therapeutic option is expected to grow. Besides, the widespread therapeutic applications for apheresis broaden its market potential. Beyond traditional uses, apheresis is finding applications in neurology, nephrology, and hematology, among other medical specialties. This diversification of applications positions apheresis as a versatile and valuable tool in various healthcare scenarios, contributing to its sustained market growth. Additionally, the growing awareness among healthcare professionals about the benefits of apheresis in managing a wide range of medical conditions further propels its adoption.

Japan Apheresis Market Segmentation:

Component Insights:

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or Leukopheresis)
• Lymphocytes (Lymphopheresis or Lymphapheresis)
• RBC's (Erythropheresis)

Product Insights:

• Devices
• Disposables and Reagents
• Software

Technology Insights:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Procedure Insights:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Application Insights:

• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

End User Insights:

• Blood Centers
• Hospitals
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan apheresis market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan apheresis market?
• What is the breakup of the Japan apheresis market on the basis of component?
• What is the breakup of the Japan apheresis market on the basis of product?
• What is the breakup of the Japan apheresis market on the basis of technology?
• What is the breakup of the Japan apheresis market on the basis of procedure?
• What is the breakup of the Japan apheresis market on the basis of application?
• What is the breakup of the Japan apheresis market on the basis of end user?
• What are the various stages in the value chain of the Japan apheresis market?
• What are the key driving factors and challenges in the Japan apheresis?
• What is the structure of the Japan apheresis market and who are the key players?
• What is the degree of competition in the Japan apheresis market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Apheresis Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Apheresis Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Apheresis Market - Breakup by Component

• 6.1 Plasma (Plasmapheresis)
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Platelets (Plateletpheresis)
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Leukocytes (Leukapheresis or Leukopheresis)
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 RBC's (Erythropheresis)
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)

7 Japan Apheresis Market - Breakup by Product

• 7.1 Devices
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Disposables and Reagents
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Software
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)

8 Japan Apheresis Market - Breakup by Technology

• 8.1 Centrifugation
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Membrane Separation
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Selective Adsorption
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)

9 Japan Apheresis Market - Breakup by Procedure

• 9.1 Donor/Automated Apheresis
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Therapeutic Apheresis
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)

10 Japan Apheresis Market - Breakup by Application

• 10.1 Renal Disorders
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2019-2024)
  • 10.1.3 Market Forecast (2025-2033)
• 10.2 Hematological Disorders
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2019-2024)
  • 10.2.3 Market Forecast (2025-2033)
• 10.3 Neurological Disorders
  • 10.3.1 Overview
  • 10.3.2 Historical and Current Market Trends (2019-2024)
  • 10.3.3 Market Forecast (2025-2033)
• 10.4 Autoimmune Disorders
  • 10.4.1 Overview
  • 10.4.2 Historical and Current Market Trends (2019-2024)
  • 10.4.3 Market Forecast (2025-2033)
• 10.5 Others
  • 10.5.1 Historical and Current Market Trends (2019-2024)
  • 10.5.2 Market Forecast (2025-2033)

11 Japan Apheresis Market - Breakup by End User

• 11.1 Blood Centers
  • 11.1.1 Overview
  • 11.1.2 Historical and Current Market Trends (2019-2024)
  • 11.1.3 Market Forecast (2025-2033)
• 11.2 Hospitals
  • 11.2.1 Overview
  • 11.2.2 Historical and Current Market Trends (2019-2024)
  • 11.2.3 Market Forecast (2025-2033)
• 11.3 Others
  • 11.3.1 Historical and Current Market Trends (2019-2024)
  • 11.3.2 Market Forecast (2025-2033)

12 Japan Apheresis Market - Competitive Landscape

• 12.1 Overview
• 12.2 Market Structure
• 12.3 Market Player Positioning
• 12.4 Top Winning Strategies
• 12.5 Competitive Dashboard
• 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

• 13.1 Company A
  • 13.1.1 Business Overview
  • 13.1.2 Product Portfolio
  • 13.1.3 Business Strategies
  • 13.1.4 SWOT Analysis
  • 13.1.5 Major News and Events
• 13.2 Company B
  • 13.2.1 Business Overview
  • 13.2.2 Product Portfolio
  • 13.2.3 Business Strategies
  • 13.2.4 SWOT Analysis
  • 13.2.5 Major News and Events
• 13.3 Company C
  • 13.3.1 Business Overview
  • 13.3.2 Product Portfolio
  • 13.3.3 Business Strategies
  • 13.3.4 SWOT Analysis
  • 13.3.5 Major News and Events
• 13.4 Company D
  • 13.4.1 Business Overview
  • 13.4.2 Product Portfolio
  • 13.4.3 Business Strategies
  • 13.4.4 SWOT Analysis
  • 13.4.5 Major News and Events
• 13.5 Company E
  • 13.5.1 Business Overview
  • 13.5.2 Product Portfolio
  • 13.5.3 Business Strategies
  • 13.5.4 SWOT Analysis
  • 13.5.5 Major News and Events

14 Japan Apheresis Market - Industry Analysis

• 14.1 Drivers, Restraints, and Opportunities
  • 14.1.1 Overview
  • 14.1.2 Drivers
  • 14.1.3 Restraints
  • 14.1.4 Opportunities
• 14.2 Porters Five Forces Analysis
  • 14.2.1 Overview
  • 14.2.2 Bargaining Power of Buyers
  • 14.2.3 Bargaining Power of Suppliers
  • 14.2.4 Degree of Competition
  • 14.2.5 Threat of New Entrants
  • 14.2.6 Threat of Substitutes
• 14.3 Value Chain Analysis

15 Appendix